PF-Atlas › Clinical Trials › NCT02048644

Effect of Fostair® on Biomarkers of Platelet Adhesion in Idiopathic Pulmonary Fibrosis

fostair · Phase 2

Registry ID

NCT02048644

Phase

Phase 2

Status

Completed

Drug / intervention

fostair

Sponsor

Hull University Teaching Hospitals NHS Trust

Start

2014-03

About this trial

fostair is evaluated in NCT02048644, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Hull University Teaching Hospitals NHS Trust. Current status: Completed.

View NCT02048644 on ClinicalTrials.gov →

Explore related

All fostair trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02048644 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.